Winston Pharmaceuticals, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WPHM research report →
Price Chart
About the company
Winston Pharmaceuticals, Inc. (WPHM) is a biopharmaceutical firm dedicated to the discovery, development, and market introduction of innovative treatments for pain. The company's pipeline and offerings address a broad spectrum of painful conditions, encompassing episodic cluster headaches, chronic migraines, various neuropathic pain syndromes, and discomfort associated with both osteoarthritis and rheumatoid arthritis.
- CEO
- Joel E. Bernstein
- IPO
- 2023
- Employees
- 9
- HQ
- Vernon Hills, IL, US
Get TickerSpark's AI analysis on WPHM
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $7.74K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.01
- P/B
- 0.01
- EV/EBITDA
- 0.57
- Div Yield
- 0.00%
- Gross Margin
- 99.35%
- Op Margin
- -196.56%
- Net Margin
- -190.40%
- ROE
- -156.02%
- ROIC
- -561.07%
Latest fiscal year · YoY change
- Revenue
- $1.39M+208.2%
- Gross Profit
- $1.39M+212.1%
- Op Income
- $-2,741,232
- Net Income
- $-2,655,316+48.4%
- EPS
- $-0.04+60.0%
- OCF Growth
- -37.1%
- FCF Growth
- -36.4%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -982.38
- RSI (14)
- 49
- Avg Volume
- 14.93K
No earnings-call transcripts are available for WPHM yet.
- Free Float
- 99.4%
- Shares Outstanding
- 77.41M
- Float Shares
- 76.98M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 19, 10 | FROST PHILLIP MD ET AL | sell | 8,779,797 |
| May 19, 10 | FROST PHILLIP MD ET AL | sell | 17,794,862 |
| Dec 16, 09 | FROST PHILLIP MD ET AL | sell | 1,741 |
| Sep 25, 09 | HALPRYN GLENN L | other | 30,000 |
| Sep 24, 09 | HALPRYN GLENN L | other | 229,000 |
| Sep 24, 09 | HALPRYN GLENN L | other | 229 |
| Sep 24, 09 | FROST PHILLIP MD ET AL | other | 4,583,000 |
| Sep 24, 09 | FROST PHILLIP MD ET AL | other | 12,476,000 |
| Sep 24, 09 | FROST PHILLIP MD ET AL | other | 8,779,797 |
| Sep 24, 09 | FROST PHILLIP MD ET AL | other | 4,583 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our WPHM coverage
Recent articles, reports, and earnings notes.
No research on WPHM yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WPHM report →